Under existing law, controlled substances may only be sold by prescription. Under existing law, the State Board of Health has the authority to add, delete, or reschedule substances as controlled substances, but the board must exclude a nonnarcotic substance from a schedule if the substance may lawfully be sold over the counter without a prescription pursuant to federal law
Controlled substances are subject to certain storage, record keeping, and security control requirements
This bill would allow ephedrine, pseudoephedrine, and phenylpropanolamine to be sold by prescription by requiring the State Board of Health to classify the drugs as Schedule III controlled substances. This bill would give the board the authority to exempt a product containing any of these substances from classification as a controlled substance if the board finds that the product is effectively formulated to prevent conversion of the active ingredient into methamphetamine or its salts or precursors. This bill would also authorize the board to revoke the exemption upon notification from the Department of Public Safety that the product exempted is not effectively formulated to prevent its conversion to methamphetamine
This bill would exempt wholesale drug distributors licensed by the Board of Pharmacy and registered with and regulated by the United States Drug Enforcement Agency from storage, reporting, and record keeping or physical security control requirements related to ephedrine and pseudoephedrine
To amend Sections 20-2-20 and 20-2-181, Code of Alabama 1975; to require the State Board of Health to classify ephedrine, pseudoephedrine, and phenylpropanolamine as controlled substances; to authorize the board to exempt from classification products that are effectively formulated to prevent their conversion to methamphetamine; to authorize the board to revoke the exemption; and to exempt certain wholesale drug distributors from reporting, storage, and security requirements for controlled substances classified as such because they contain ephedrine, pseudoephedrine, or phenylpropanolamine.
|February 7, 2012||Read for the first time and referred to the House of Representatives committee on Health|
|Bill Text||HB92 Alabama 2012 Session - Introduced|